Bullet flag-united-kingdom flag-ireland


  • Respiratory

Small Airway Disease in Asthma

Small airways disease is present patients with asthma across all severity levels.1 Moreover, studies in patients with asthma have shown that the involvement of small airways represents a crucial step in the progression of the disease.2 In his presentation, Dr Richard Russell describes the importance of small airway disease in asthma, in terms of disease pathophysiology and patient outcomes, and how timely diagnosis is key for effective patient care. The impact of small airways disease on patients’ overall phenotype is also a key focus of this talk.

The different tools and measures available for the diagnosis of small airways disease and the feasibility of their use in clinical practice are also discussed.

Dr Russell contextualises the findings from the ATLANTIS study with real-world case studies, highlighting the importance of early and accurate diagnosis of small airways disease.


  1. 1. Postma et al. Unmet needs for the assessment of small airways dysfunction in asthma: introduction to the ATLANTIS study. 2015. European Respiratory Journal: 45(6): p 1534-1538.
  2. 2. Bjermer, L. The role of small airway disease in asthma. 2014. Current Opinion in Pulmonary Medicine: 20(1): p 23-30.

We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.

Dr Richard Russell

Dr Richard Russell is the Principal Investigator in Experimental Medicine in the Respiratory Department at Oxford. His research interests include the basic mechanisms underlying the pathophysiology of COPD and asthma, and how these could lead to new therapeutic opportunities.

Dr Russell is also a Consultant Physician at Lymington New Forest Hospital and Director of the Hampshire Community Integrated Respiratory Service, responsible for asthma and COPD care in community.

Outside of the clinic, Dr Russell is an Honorary Senior Lecturer at Imperial College London and the Editor-in-Chief for the International Journal of COPD.